Skip to main content
. 2021 Jan 4;2021(1):CD013630. doi: 10.1002/14651858.CD013630.pub2

NCT01502280 (BALANCE).

Study name Fluorescence‐guided surgery for low‐ and high‐grade gliomas
Methods Randomised. Single‐blind
Participants Newly diagnosed glioma (HGG and LGG)
Interventions 5‐ALA (Gliolan) vs placebo (ascorbic acid)
Outcomes Volume of residual disease; overall survival; and 6‐month progression‐free survival
Starting date November 2010
Contact information Nader Sanai (principal investigator), Norissa Honea (overall contact)
Notes Barrow, Phoenix, AZ, USA